ThinkingNode Life Science, Inc.
Ash Damle is the founder of Healiom, a healthcare innovation addressing complexities in the sector through AI integration with existing infrastructure. Since August 2020, Ash has led significant roles in various companies, serving as the head of artificial intelligence and CTO in both Stealth Startup and ThinkingNode Life Science, Inc., which focuses on rapid digital cell cloning for drug R&D. Additionally, Ash advises at The Modern Data Company and PolymerHQ DLP, working on modern data solutions and governance. Ash’s expertise extends to advisory roles at Loop Health, Ellipsis Health, and PeerWell, improving healthcare access and outcomes. Prior experience includes serving as Chief Data Scientist at HealthCare.com. Ash holds a degree from the Massachusetts Institute of Technology.
This person is not in any teams
ThinkingNode Life Science, Inc.
ThinkingNodeLife.ai (TNL) is the first AI Digital Cells Lab that can generate mechanistic digital human cell clones within a few hours using -omics data. This allows the prediction and the understanding of the impacts of molecules or drugs on any human cells of interest. By being able to mechanistically identify novel disease-targets and to simulate each drug in various R&D phases, TNL provides a decisive advantage for developing both first-in-class and best-in-class drugs. This impacts the entire drug R&D value chain in multiple ways. For example, all assets of a pharmaceutical company can be prioritized for early development and existing launched products can be quickly repurposed for new indications. The TNL AI Digital Cells Lab has already proven its effectiveness in serving biopharmaceutical customers, particularly in the realms of cancer and autoimmune diseases. All this is possible based on its novel Generative Distributed Reasoning AI (GDR-AI) that employs Distributed Reasoning AI instead of statistical correlation to generate causal reasoning models. Khai Pham, MD & PhD (AI) (Sorbonne University), is the founder & CEO of TNL. He has been in the AI field for 30 years. Few have worked on unifying AI across different approaches (Machine Learning, Reasoning AI, and Distributed Multi-Agent AI). He is the leading expert in Distributed AI. The first generation of his Distributed AI was used in his first AI company (acq. by Nasdaq: EPNY for $637M). At TNL, he is surrounded by an amazing multi-disciplinary executive team that has been involved in $10+B total exits.